Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-31

Clinical Trial Update: Efficacy and Safety of Intravitreal Bevacizumab in the Treatment of Choroidal Neovascular Membranes Associated to High Myopia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating intravitreal bevacizumab for choroidal neovascular membranes associated with high myopia has completed, reporting on efficacy and saf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avastin (bevacizumab)

Snippet

Sponsor: Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA | Conditions: Myopia, Choroidal Neovascularization | Phase 3 | Status: COMPLETED